ArticleOrphanet journal of rare diseases2019

Systemic bevacizumab for high-output cardiac failure in hereditary hemorrhagic telangiectasia: an international survey of HHT centers.

Hanny Al-Samkari et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.